The partnership intends to create a vaccine or vaccines which target cells at the pre-cancerous stage before the disease has ...
The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback